THE annual release of the Australian Prescriber's top ten subsidised drugs in Australia for 2015-16 has seen the new hepatitis C listed drugs taking the very high profile position as highest cost to government, in spite of relatively low patient numbers compared to the script number rankings.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 05 Dec 16
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Dec 16
